Upstream Bio (UPB) Restructuring Costs (2024 - 2026)

Upstream Bio's Restructuring Costs history runs 3 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Restructuring Costs rose 5.6% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $4.6 million (up 77.37% YoY), while the FY2025 annual figure was $4.5 million, up 127.77% from the prior year.
• Restructuring Costs for Q1 2026 stood at $1.1 million, down from $1.3 million in the prior quarter.
• The five-year high for Restructuring Costs was $1.3 million in Q4 2025, with the low at $334000.0 in Q2 2024.
• The 3-year median for Restructuring Costs is $891000.0 (2025), against an average of $843666.7.
• The sharpest annual moves came in 2025 and 2026: Restructuring Costs jumped 273.95% in 2025, then rose 5.6% in 2026.
• Upstream Bio's Restructuring Costs stood at $836000.0 in 2024, then soared by 56.58% to $1.3 million in 2025, then declined by 14.97% to $1.1 million in 2026.
• Business Quant data shows UPB's Restructuring Costs at $1.1 million in Q1 2026, $1.3 million in Q4 2025, and $891000.0 in Q3 2025.